Acurx Pharmaceuticals, Inc. (ACXP) stock
ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.94−0.02 (-2.60%)
Close on Nov 16, 2026Market cap $4.93MP/E –Yield –
Acurx Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Acurx Pharmaceuticals's price to book ratio was 0.6× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.6× to 19.6×, with a median of 4.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −0.6 |
| 2025 | Dec 31, 2025 | 1.2× | −2.6 |
| 2024 | Dec 31, 2024 | 3.8× | −2.3 |
| 2023 | Dec 29, 2023 | 6.1× | +1.4 |
| 2022 | Dec 30, 2022 | 4.6× | +1.6 |
| 2021 | Dec 31, 2021 | 3.1× | – |
See a number that looks wrong?